Pfizer
PFE
PFE
2,430 hedge funds and large institutions have $130B invested in Pfizer in 2020 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 987 increasing their positions, 1,117 reducing their positions, and 181 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $157B → $130B (-$26.8B)
31% less first-time investments, than exits
New positions opened: 124 | Existing positions closed: 181
33% less call options, than puts
Call options by funds: $876M | Put options by funds: $1.31B
Holders
2,430
Holding in Top 10
140
Calls
$876M
Puts
$1.31B
Top Buyers
| 1 | +$1.18B | |
| 2 | +$814M | |
| 3 | +$392M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$314M |
| 5 |
D.E. Shaw & Co
New York
|
+$272M |
Top Sellers
| 1 | -$1.3B | |
| 2 | -$450M | |
| 3 | -$412M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$399M |
| 5 |
Goldman Sachs
New York
|
-$374M |